Cite
Antispike Immunoglobulin-G (IgG) Titer Response of SARS-CoV-2 mRNA-Vaccine (BNT162b2): A Monitoring Study on Healthcare Workers
MLA
Alessio Danilo Inchingolo, et al. “Antispike Immunoglobulin-G (IgG) Titer Response of SARS-CoV-2 MRNA-Vaccine (BNT162b2): A Monitoring Study on Healthcare Workers.” Biomedicines, vol. 10, no. 10, Sept. 2022, p. 2402. EBSCOhost, https://doi.org/10.3390/biomedicines10102402.
APA
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, Assunta Patano, Alberto Corriero, Daniela Azzollini, Grazia Marinelli, Giovanni Coloccia, Fabio Piras, Giuseppe Barile, Vito Settanni, Antonio Mancini, Nicole De Leonardis, Grazia Garofoli, Giulia Palmieri, Ciro Gargiulo Isacco, Biagio Rapone, Megan Jones, Ioana Roxana Bordea, … Francesco Inchingolo. (2022). Antispike Immunoglobulin-G (IgG) Titer Response of SARS-CoV-2 mRNA-Vaccine (BNT162b2): A Monitoring Study on Healthcare Workers. Biomedicines, 10(10), 2402. https://doi.org/10.3390/biomedicines10102402
Chicago
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, Assunta Patano, Alberto Corriero, Daniela Azzollini, Grazia Marinelli, et al. 2022. “Antispike Immunoglobulin-G (IgG) Titer Response of SARS-CoV-2 MRNA-Vaccine (BNT162b2): A Monitoring Study on Healthcare Workers.” Biomedicines 10 (10): 2402. doi:10.3390/biomedicines10102402.